D1 and D2 dopamine receptors — Drug Target

All drugs that target D1 and D2 dopamine receptors — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Dopamine agonist

Phase 3 pipeline (1)

• Continuous Subcutaneous Lisuride Infusion · Axxonis Pharma AG · Dopamine agonist · Neurology
  Lisuride is a dopamine agonist that activates dopamine receptors to improve motor symptoms and reduce involuntary movements in Parkinson's disease.